This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64656491
rdf:type
wikibase:Item
schema:description
ensayu clínicu клінічне випробування կլինիկական փորձարկում klinisch onderzoek clinical trial
rdfs:label
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
skos:prefLabel
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
schema:name
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
p:P1476
wds:Q64656491-DE9F578E-7A79-4647-9A16-E4FCB8D1EF52
wdt:P1476
A Phase II Study of Bortezomib, Liposomal Doxorubicin, Dexamethasone, and Cyclophosphamide in Patients With Multiple Myeloma Relapsing Within 12 Months of Autologous Stem Cell Transplant
p:P582
wds:Q64656491-6EB00A11-9B7D-4ADD-9C4E-66AD81123580
wdt:P582
2014-02-01T00:00:00Z
p:P31
wds:Q64656491-92DA0572-5123-4D1E-AADF-5B8B6BB3A89F
wdt:P31
wd:Q30612
p:P580
wds:Q64656491-04C86DD7-AE55-4D8A-B958-9FD548EDA024
wdt:P580
2010-09-01T00:00:00Z
p:P17
wds:Q64656491-561E78F4-339C-4EC2-BA42-1652C0887626
wdt:P17
wd:Q30
p:P6153
wds:Q64656491-B2B96916-6B75-4222-BFCA-54E0558DADED wds:Q64656491-C46D3889-8617-4A1B-A004-7AE0E65C8409 wds:Q64656491-9E828D9B-D3B4-4EE7-8E73-BC362AB92181 wds:Q64656491-A8A7DE52-3CB4-4495-A86C-E278D88BEF29 wds:Q64656491-AB366612-F455-4D33-AB83-DF4DD91EA3CA wds:Q64656491-7BBAB15C-19E3-4F48-9E39-002C91D16CEE wds:Q64656491-92430710-F7B2-4D64-95BC-AF7FFA930ACD wds:Q64656491-25F1EE5B-8EFA-47F7-88F3-66B77AB5161D wds:Q64656491-3F2AABAB-9453-4830-AAB8-F6396529084A wds:Q64656491-DD7A1CCE-4E3C-4B09-B5A5-0B24138912BF wds:Q64656491-FFDC4208-8F71-4F6E-AE7D-757582620992
wdt:P6153
wd:Q6806287 wd:Q30254005 wd:Q5714832 wd:Q2302319 wd:Q30280192 wd:Q1130172 wd:Q30281040 wd:Q7654755 wd:Q3145247 wd:Q30270451 wd:Q5330089
p:P4844
wds:Q64656491-C9B4B3C8-EB79-4A9F-81E3-0EF6F9AF8036 wds:Q64656491-14F95494-ACEA-4764-9C37-054AF2D029CD wds:Q64656491-DCDC8F77-2D02-4AB4-B78B-B14DECF62EFC
wdt:P4844
wd:Q18936 wd:Q408524 wd:Q29004943
p:P2899
wds:Q64656491-4BB37ECD-3031-40CA-B138-8E9691C36964
wdt:P2899
18
p:P1050
wds:Q64656491-D2908FF8-EFBB-4019-8ACF-7521A99B8627
wdt:P1050
wd:Q467635
p:P1132
wds:Q64656491-7DBD8F0D-AAE6-4085-80E4-1C9A0D47E218
wdt:P1132
2
p:P8363
wds:Q64656491-9C22C4AF-AFF5-4F0C-8A0D-D59C95E5E6F9
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64656491-5D0121B6-C63F-4DE1-9BE5-F1AA8CA32553
wdt:P3098
NCT01078441
p:P6099
wds:Q64656491-222C7510-126E-4E49-B5D0-1C69F8D3FDA7
wdt:P6099
wd:Q42824440